Comparison of Sirolimus-Eluting Stenting With Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary Artery

被引：59

作者：

Blazek, Stephan ^{[1
]}

Rossbach, Cornelius ^{[1
]}

Borger, Michael A. ^{[2
]}

Fuernau, Georg ^{[1
]}

Desch, Steffen ^{[1
,3
]}

Eitel, Ingo ^{[1
,3
]}

Stiermaier, Thomas ^{[1
]}

Lurz, Philipp ^{[1
]}

Holzhey, David ^{[2
]}

Schuler, Gerhard ^{[1
]}

Mohr, Friedrich-Wilhelm ^{[2
]}

Thiele, Holger ^{[1
,3
]}

机构：

[1] Univ Leipzig, Ctr Heart, Dept Internal Med Cardiol, D-04109 Leipzig, Germany

[2] Univ Leipzig, Ctr Heart, Dept Cardiac Surg, D-04109 Leipzig, Germany

[3] Univ Lubeck, Med Clin 2, Lubeck, Germany

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2015年 / 8卷 / 01期

关键词：

Bypass surgery; Drug-eluting stent; Left anterior descending artery; Long-term follow-up; Percutaneous coronary intervention;

D O I：

10.1016/j.jcin.2014.08.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OBJECTIVES: The aim of this analysis was to assess the 7-year long-term safety and effectiveness of a randomized comparison of percutaneous coronary intervention (PCI) with sirolimus-eluting stents (SES) versus minimally invasive direct coronary artery bypass (MIDCAB) surgery for the treatment of isolated proximal left anterior descending lesions. BACKGROUND: Long-term follow-up data comparing PCI by SES and MIDCAB surgery for isolated proximal left anterior descending lesions are sparse. METHODS: Patients were randomized either to PCI with SES (n = 65) or MIDCAB (n = 65). Follow-up data were obtained after 7 years with respect to the primary composite endpoint of death, myocardial infarction, and target vessel revascularization. Angina was assessed by the Canadian Cardiovascular Society classification and quality of life with Short Form 36 and MacNew quality of life questionnaires. RESULTS: Follow-up was conducted in 129 patients at a median time of 7.3 years (interquartile range: 5.7, 8.3). There were no significant differences in the incidence of the primary composite endpoint between groups (22% PCI vs. 12% MIDCAB; p = 0.17) or the endpoints death (14% vs. 17%; p = 0.81) and myocardial infarction (6% vs. 9%, p = 0.74). However, the target vessel revascularization rate was higher in the PCI group (20% vs. 1.5%; p < 0.001). Clinical symptoms and quality of life improved significantly from baseline with both interventions and were similar in magnitude between groups. CONCLUSIONS: At 7-year follow-up, PCI by SES and MIDCAB in isolated proximal left anterior descending lesions yielded similar long-term outcomes regarding the primary composite clinical endpoint and quality of life. Target vessel revascularization was more frequent in the PCI group. © 2015 by the American College of Cardiology Foundation.

引用

页码：30 / 30

页数：1

共 28 条

[11] Valenti L., Lim L., Heller R.F., Knapp J., An improved questionnaire for assessing quality of life after acute myocardial infarction, Qual Life Res, 5, pp. 151-161, (1996)
[12] Ware J.E., SF-36 health survey update, Spine (Phila Pa 1976), 25, pp. 3130-3139, (2000)
[13] Klein J.P., Moeschberger M.L., Survival Analysis: Techniques for Censored and Truncated Data. 2nd Edition, (2003)
[14] Fihn S.D., Gardin J.M., Abrams J., Et al., 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and mgmt. Of patients with stable ischemic heart Dis.: A report of the Amer. Coll. Of Cardiol. Found./Amer. Heart Assoc. Task Force on Practice Guidelines, and the Amer. Coll. Of Physicians, Amer. Assoc. For Thorac. Surg., Prev. Cardiovasc. Nurses Assoc., Soc. For Cardiovasc. Angiography and Interventions, and Soc. Of Thorac. Surgs, J Am Coll Cardiol, 60, pp. e44-e164, (2012)
[15] Montalescot G., Sechtem U., Et al., 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Eur Heart J, 34, pp. 2949-3003, (2013)
[16] Etienne P.Y., D'Hoore W., Papadatos S., Et al., Five-year follow-up of drug-eluting stents implantation vs minimally invasive direct coronary artery bypass for left anterior descending artery disease: A propensity score analysis, Eur J Cardiothorac Surg, 44, pp. 884-890, (2013)
[17] Kerner A., Abergel E., Halabi M., Et al., Should proximal LAD be treated differently? Insights from a large DES stent registry, Cardiovasc Revasc Med, 14, pp. 325-332, (2013)
[18] Calais F., Lagerqvist B., Leppert J., James S.K., Frobert O., Proximal coronary artery intervention: Stent thrombosis, restenosis and death, Int J Cardiol, 170, pp. 227-232, (2013)
[19] Cameron A., Davis K.B., Green G., Schaff H.V., Coronary bypass surgery with internal-thoracicartery grafts-effects on survival over a 15-year period, N Engl J Med, 334, pp. 216-219, (1996)
[20] Goy J.J., Kaufmann U., Hurni M., Et al., 10-Year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial, J Am Coll Cardiol, 52, pp. 815-817, (2008)

← 1 2 3 →